The 2 most recent market catalysts affecting $BCYC, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Oct 29, 2026
Corporate Catalyst
Bullish
Impact 75
Bicycle Therapeutics Reports Third Quarter 2026 Financial Results and Business Progress
Bicycle Therapeutics reported strong third-quarter 2026 results, with collaboration revenue up significantly and a substantial narrowing of its net loss. This financial improvement…
Jul 30, 2026
Corporate Catalyst
Bearish
Impact 95
Bicycle Therapeutics Q2 EPS $(0.72) Misses $(0.59) Estimate, Sales $629.000K Miss $4.221M Estimate
Bicycle Therapeutics announced Q2 results that fell significantly short of analyst expectations. The company's reported loss of $(0.72) per share missed estimates by 22.03%, and mo…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.